Rare diseases
Investigational molecules
Locations
Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
BelgiumStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
BelgiumStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
BelgiumStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
BelgiumStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
BulgariaStudy on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BelgiumStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
BelgiumStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
AustriaStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
